General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company

Products	General Side Effect Profile I (GEN SEP I) from Novascreen-a Caliper Life Sciences Company
Company	Novascreen-a Caliper Life Sciences Company
Item	General Side Effect Profile I (GEN SEP I)
Price
Description	Compound(s) tested through 63 ligand binding and enzyme assays spanning a broad therapeutic range. This assay panel includes many non human tissue sources and several non-selective assays. Used to determine potential side-effect liabilities of compounds.
Info	Novascreen-a Caliper Life Sciences Company 7170 Standard Drive Hanover, Maryland 21076-1334 USA Customer Service: 410-712-4410 Fax Number: 410-712-4412 Web Site: http://www.novascreen.com/

NOTE: Price information is approximate list price and actual prices may vary.

Immunogen: Synthetic peptide: R(89) L A F T V D D N P T K P T T R Q R Y(107) Storage: -20 C, Avoid Freeze/Thaw Cycles...

...

Request Info...

CREB-2 (H-290)...

Biology Products:

Rabbit Anti-WW domain-containing oxidoreductase Antibody, Unconjugated from ABR-Affinity BioReagents Yeast Nitrogen Base from Invitrogen Histidine-tagged Protein Purification Resin from R&D Systems Rabbit Anti-CREB-2 (H-290) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

(Date:11/11/2019)... ... November 11, 2019 , ... MicroGenDX, the world leader ... role in the award-winning study “Next Generation Sequencing for the Diagnosis of Periprosthetic ... laboratory processed samples using Next Generation DNA Sequencing to examine the ability of ...

(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...

(Date:11/6/2019)... (PRWEB) , ... November 06, 2019 , ... ... version 2.0 today. The Genomic Search Engine now includes the ability to ... will further accelerate diagnosis of patients with genetic and rare diseases. , Patients, ...

Breaking Biology News(10 mins):

[0] MicroGenDX Next-Gen DNA Sequencing Used in Breakthrough Knee Infection Study: Rothman Institute Accepts Eastern Orthopaedic Association’s Musculoskeletal Infection Award [0] R3 Stem Cell Online Training Course Now 50% Off Through January 1, 2020 [0] Genomenon Accelerates Rare and Genetic Disease Research with Mastermind v2.0

(Date:12/2/2019)... ... 2019 , ... Registration is now open for the American Society ... the Hynes Convention Center May 12-15, 2020, in Boston. The meeting is the premier ... patient advocates, and other stakeholders with the goal of advancing gene and cell therapies ...

(Date:11/19/2019)... ... November 19, 2019 , ... Supercomputing Conference – ... infrastructure solutions for Autonomous Vehicle , Medical Imaging, and Natural Language Processing ... with the Graphcore Poplar® software stack as part of its bare-metal cloud service ...

(Date:11/12/2019)... ... 12, 2019 , ... Peggy Lillis Foundation (PLF) has launched ... infection C. diff. The campaign, “See C. diff,” combines basic facts ... 30,000 people in the U.S. each year. The campaign also features a portrait ...

(Date:11/5/2019)... ... November 05, 2019 , ... Focal ... CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining ... Fusion Bx 2.0 will give urologists across Europe the ability to perform targeted ...

Breaking Biology Technology:

[0] Registration Opens Today for ASGCT's 23rd Annual Meeting in Boston [0] Cirrascale Cloud Services Announces Availability of Graphcore IPU Servers and Cloud Instances for Machine Intelligence Workflows [0] Raising Awareness of Rampant Deadly Infection, “See C. diff” Campaign Aims to Save Lives [0] Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark